| 发明名称 |
USE OF gp130 ACTIVATORS IN DIABETIC NEUROPATHY |
| 摘要 |
The invention relates to the use a substance signaling through gp130 for the manufacture of a medicament for the treatment and/or prevention of diabetic neuropathy. The use of IL-6 is preferred. |
| 申请公布号 |
US2010189684(A1) |
申请公布日期 |
2010.07.29 |
| 申请号 |
US20100754335 |
申请日期 |
2010.04.05 |
| 申请人 |
MERCK SERONO SA |
发明人 |
DREANO MICHEL;VITTE PIERRE-ALAIN |
| 分类号 |
A61K38/20;A61K45/00;A61K31/7088;A61K35/12;A61K38/00;A61K38/17;A61K39/395;A61K47/48;A61K48/00;A61P3/10;A61P25/00;A61P25/02 |
主分类号 |
A61K38/20 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
